Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126718491 | 12671849 | 1 | I | 20151021 | 20160809 | 20160822 | 20160822 | EXP | GB-MHRA-EYC 00143359 | GB-TEVA-684593ACC | TEVA | 66.00 | YR | F | Y | 83.00000 | KG | 20160822 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126718491 | 12671849 | 1 | PS | ATORVASTATIN | ATORVASTATIN | 1 | Oral | U | 78773 | 20 | MG | ||||||||
| 126718491 | 12671849 | 2 | C | FOSTAIR | BECLOMETHASONEFORMOTEROL | 1 | 0 | ||||||||||||
| 126718491 | 12671849 | 3 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 0 | ||||||||||||
| 126718491 | 12671849 | 4 | C | LOSARTAN. | LOSARTAN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126718491 | 12671849 | 1 | Cardiovascular event prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126718491 | 12671849 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126718491 | 12671849 | Dyspnoea | |
| 126718491 | 12671849 | Interstitial lung disease |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126718491 | 12671849 | 1 | 20151021 | 20160620 | 0 |